US Supreme Court Will Not Review Contrave Case

Teva’s Actavis Fails To Convince Top Court To Review Split Decision

US Supreme Court building facade with words Equal Justice
The Supreme Court has turned down Actavis’ request for certiorari review • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Legal & IP

More from Generics Bulletin